6
Oct
2026

Polpharma Biologics

Exhibitor at CPHI Milan 2026 stand 7A92, Integrated Pharma
About Us

Polpharma Biologics is a Swiss-headquartered biosimilar company focused on accelerating access to biologic medicines through science, agility, and smart partnerships. With a lean, flexible model and a strong legacy, it enables cost-efficient development and global scalability. With multiple approved biosimilars and a robust pipeline—including first-to-launch assets—Polpharma Biologics partners globally to deliver affordable, high-quality biologics to patients worldwide.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Poland
  • On CPHI since:
    2021
  • Certificates:
    3
  • Employees:
    50 - 99
Company types
Biopharmaceutical company
Generics/Biosimilars Manufacturer
Primary activities
Biopharmaceutical
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 7A92, Integrated Pharma

Products Featured at CPHI Milan 2026

  • Pipeline

    Product Pipeline

    With approved biosimilars already on the market and a robust pipeline of differentiated assets,Polpharma Biologics is well-positioned to shape the future of biosimilars. Strategic collaborationswith industry leaders demonstrate the company’s ability to co-create value and deliver at scale.

Polpharma Biologics Resources (1)